Eris Lifesciences Limited has informed the Exchange about Schedule of meet
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has informed exchanges about a scheduled conference call with analysts and investors on Tuesday, August 5, 2025, at 5:30 PM IST. The call will discuss the company's financial and operational performance for Q1 FY26 (quarter ended June 30, 2025). This follows the earlier intimation dated July 30, 2025, regarding the Board of Directors meeting to approve the unaudited standalone and consolidated financial results. The webcast details and registration link have been shared, and the invite is also available on the company's website.
This is a routine procedural disclosure with no direct impact on the stock price. Investors should watch the August 5 call for management commentary on Q1 FY26 performance, which may provide forward-looking cues.